Additionally, diltiazem has been shown to exert anti-inflammatory effects by modulating cytokine production, including IL-10 and IL-6 (Dubey and Hesong, 2006), further supporting its potential role in neurodegenerative disease management. This evidence concerns the gene IL10 and neurodegenerative disease.